Association of β2-adrenoreceptor variants with bronchial hyperresponsiveness

被引:53
|
作者
Ulbrecht, M
Hergeth, MT
Wjst, M
Heinrich, J
Bickeböller, H
Wichmann, HE
Weiss, EH
机构
[1] Univ Munich, Inst Anthropol & Human Genet, D-80333 Munich, Germany
[2] GSF Forschungszentrum Umwelt & Gesundheit GMBH, Inst Epidemiol, Oberschleissheim, Germany
[3] Tech Univ Munich, Inst Med Stat & Epidemiol, D-8000 Munich, Germany
关键词
D O I
10.1164/ajrccm.161.2.9902072
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Because of its involvement in the regulation of airway tone, the beta(2)-adrenoreceptor is considered a candidate for bronchial hyperresponsiveness (BHR) associated with asthma. This notion is supported by several reports that have implicated the chromosomal region 5q31-q33 harboring the gene for the beta(2)-adrenoreceptor in the genetics of asthma and related phenotypes. We performed a population-based association study focusing on BHR as a qualitative trait and omitting other asthma-related phenotypes. From a German population sample of 1,150 individuals we extracted all 152 bronchohyperreactive probands, who were compared with 295 bronchonormoreactive control subjects. All individuals were genotyped for three single nucleotide polymorphisms of the beta(2)-adrenoreceptor gene resulting in variants at the amino acid positions 16, 27, and 164. The genotyping protocol used allowed the determination of haplotypes of these polymorphisms. Whereas no individual polymorphism was associated with BHR, the Gly16/Gln27/Th164 haplotype was significantly underrepresented in the case group indicating a protective effect of this haplotype with regard to BHR. Upon reanalysis by sex a significant association persisted only for female probands.
引用
收藏
页码:469 / 474
页数:6
相关论文
共 50 条
  • [21] BETA 2-ADRENORECEPTOR TRAFFICKING IS ALTERED IN POSTBURN DERMAL FIBROBLASTS
    El Ayadi, A.
    Prasai, A.
    Wang, Y.
    Herndon, D. N.
    Finnerty, C. C.
    WOUND REPAIR AND REGENERATION, 2017, 25 (04) : A8 - A8
  • [22] Association of β2-adrenoreceptor genotypes with prevention of COPD exacerbations by tiotropium or salmeterol in the POET-COPD® trial
    Koegler, Harald
    Rabe, Klaus F.
    Beeh, Kai M.
    Glaab, Thomas
    Schmidt, Hendrik
    Fabbri, Leonardo M.
    Vogelmeier, Claus
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [23] beta 2-adrenoreceptor immunoreactivity in cardiac ganglia of the guinea pig
    Haberberger, R
    Kummer, W
    HISTOCHEMICAL JOURNAL, 1996, 28 (11): : 827 - 833
  • [24] Polymorphisms in the β2-adrenoreceptor gene are associated with decreased airway responsiveness
    Ramsay, CE
    Hayden, CM
    Tiller, KJ
    Burton, PR
    Goldblatt, J
    Lesouef, PN
    CLINICAL AND EXPERIMENTAL ALLERGY, 1999, 29 (09): : 1195 - 1203
  • [25] Different effects of Gsα splice variants on β2-adrenoreceptor-mediated signaling -: The β2-adrenoreceptor coupled to the long splice variant of Gsα has properties of a constitutively active receptor
    Seifert, R
    Wenzel-Seifert, K
    Lee, TW
    Gether, U
    Sanders-Bush, E
    Kobilka, BK
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (09) : 5109 - 5116
  • [26] Beta 2-adrenoreceptor agonists: a new perspective in the treatment of asthma?
    Quadrelli, SA
    Roncoroni, AJ
    Pinna, DM
    MEDICINA-BUENOS AIRES, 1999, 59 (03) : 293 - 299
  • [27] α-synuclein expression is not mediated by β2-adrenoreceptor modulation in human dopaminergic cells
    Langmyhr, M.
    Flones, I. H.
    Cappelletti, C. C.
    Tzoulis, C.
    Toft, M.
    MOVEMENT DISORDERS, 2021, 36 : S218 - S218
  • [28] Structural equilibrium underlying ligand-dependent activation of β2-adrenoreceptor
    Imai, Shunsuke
    Yokomizo, Tomoki
    Kofuku, Yutaka
    Shiraishi, Yutaro
    Ueda, Takumi
    Shimada, Ichio
    NATURE CHEMICAL BIOLOGY, 2020, 16 (04) : 430 - +
  • [30] Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease
    Hopfner, Franziska
    Wod, Mette
    Hoeglinger, Guenter U.
    Blaabjerg, Morten
    Roesler, Thomas W.
    Kuhlenbaeumer, Gregor
    Christensen, Kaare
    Deuschl, Guenther
    Pottegard, Anton
    NEUROLOGY, 2019, 93 (02) : E135 - E142